Cargando…
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic cancer is one of the cancers with the highest mortality rate, and targeted therapy against specific genes that play a crucial role in cancer is the latest therapeutic approach. This study showed that CD73 is highly expressed in pancreatic cancer, and the application of CRI...
Autores principales: | Zhang, Jinping, Zhang, Shuman, Dörflein, Isabella, Ren, Xiaofan, Pfeffer, Susanne, Britzen-Laurent, Nathalie, Grützmann, Robert, Duan, Xianglong, Pilarsky, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572021/ https://www.ncbi.nlm.nih.gov/pubmed/37835536 http://dx.doi.org/10.3390/cancers15194842 |
Ejemplares similares
-
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2022) -
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
por: Yang, Hai, et al.
Publicado: (2022) -
Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator
por: He, Hang, et al.
Publicado: (2022) -
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
por: Zeng, Siyuan, et al.
Publicado: (2022) -
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)